In this review, we have attempted to consolidate the existing data on neurotrophin-based pharmaceutics and their role in the modulation of neuroinflammation and outline future prospects for their application in the treatment of neurodegenerative diseases. This evidence concerns the gene BDNF and neurodegenerative disease.